Dietary Factors in the Modulation of Inflammatory Bowel Disease Activity

Shinil Shah, DO, PGY-1


March 27, 2007


A case report of 2 patients may indicate the potential use of bromelain as an adjunctive agent in the treatment of ulcerative colitis. The 2 patients were unable to achieve remission on standard therapy. Clinical and endoscopic evidence of improvement was documented. Bromelain is derived from the stems of pineapple, and is believed to be a proteolytic enzyme.[54] A more recent study, documenting the use of bromelain in an IL-10-deficient murine model of IBD, demonstrated that bromelain supplementation resulted in decreased clinical and histological severity of colonic inflammation. The proteolytic property of bromelain is necessary for its anti-inflammatory properties, and some hypothesize that cell surface molecules and consequently T-cell activation may be altered by bromelain.[55]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.